Home › Trial NCT06963346
Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents
- Trial IDNCT06963346
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorH. Lee Moffitt Cancer Center and Research Institute
- Enrollment12
- Start date2025-06-24
- ConditionsBladder Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.